Emergency Department, Rapid Assessment for Sexually Transmitted Infection

NCT02386514 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2017-01-04

No results posted yet for this study

Summary

To evaluate if a rapid urine Nucleic Acid Amplification Testing (NAAT) is non-inferior to the traditional swab NAAT for gonorrhea and chlamydia when performed in the Emergency Department.

Conditions

Sponsors & Collaborators

  • Cepheid

    collaborator INDUSTRY
  • Henry Ford Health System

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02386514 on ClinicalTrials.gov